. Author manuscript; available in PMC: 2022 Jan 1.

Published in final edited form as: Ann Surg Oncol. 2020 Oct 30;28(1):48–56. doi: 10.1245/s10434-020-09274-z

Table 1 –

Patient Characteristics

	Included Patients (N = 393)	Excluded Patients (N = 270)	p-value
Age (SD)	63.3 (14.1)	64.6 (14.3)	0.3
Female	164 (41.7%)	102 (41.5%)	>0.9
BMI (SD)	26.8 (5.6)	26.9 (5.1)	0.8
Stage Early (cT1–2) Locally advanced (cT3–4)	185 (47.1%) 208 (52.9%)	76 (33.9%) 148 (66.1%)	0.002
Neoadjuvant Chemo Adjuvant Chemo	157 (39.9%) 129 (32.8%)	124 (50.4%) 147 (59.8%)	0.012 <0.001
Extent of Resection Subtotal/distal Total/proximal	241 (61.3%) 152 (38.7%)	129 (52.4%) 117 (47.6%)	0.033
Surgical Approach Open Minimally invasive	321 (81.7%) 72 (18.3%)	170 (69.1%) 76 (30.9%)	<0.001
Complications (G3+)	32 (8.1%)	50 (18.5%)	<0.001

SD – standard deviation